Dried Blood Spot Testing for Detection of Congenital Cytomegalovirus - Reply

Mark R. Schleiss, Mark T. McCann, Sheila C. Dollard

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)865-866
Number of pages2
JournalJAMA Pediatrics
Volume175
Issue number8
Early online dateMay 3 2021
DOIs
StatePublished - Aug 2021

Bibliographical note

Funding Information:
Funding/Support: This research was supported by the National Institute on Drug Abuse of the National Institutes of Health (grant 3U54DA036151-08S2) and the US Food and Drug Administration Center for Tobacco Products. Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Disclaimer: The content is solely the responsibility of the author and does not necessarily repesent the official views of the National Institutes of Health or the US Food and Drug Administration. 1. Yang Y, Lindblom EN, Salloum RG, Ward KD. The impact of a comprehensive tobacco product flavor ban in San Francisco among young adults. Addict Behav Rep. 2020;11:100273. 2. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT). Statement on the potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS—e-cigarettes). Published September 2020. Accessed December 18, 2020. https://cot.food.gov.uk/sites/default/files/2020-09/COT%20E%28N%29NDS %20statement%202020-04.pdf. 3. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems; Eaton DL, Kwan LY, Stratton K, eds. Public Health Consequences of E-Cigarettes. National Academies Press; 2018.

Funding Information:
Institutes of Health HD098866 and grants from University of South Carolina Disability Research and Dissemination Center Subaward 20-3983 during the conduct of the study and personal fees from Moderna, Merck, Sanofi, and GlaxoSmithKline outside the submitted work. Dr McCann reported grants from the US Centers for Disease Control and Prevention during the conduct of the study. No other disclosures were reported.

Cite this